Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Gemcitabine
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01
- Strength
- 1000 G
- Dosage form
- Injection
- Pack
- Per vial
- Registration no.
- 072562
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-12 02:58
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Celzar 1000 (Gemcitabine) is used for
Gemcitabine is a chemotherapy (cancer) medicine. It is a cytotoxic medicine, which means it kills cells that are dividing, including cancer cells, and slows or stops the growth of cancer. It can be given on its own or together with other cancer medicines. It is a hospital medicine: it is started and given by cancer specialists, as a drip into a vein, by a doctor or nurse in a medical facility.
- Non-small cell lung cancer
- Pancreatic cancer
- Breast cancer (given with another cancer medicine, paclitaxel)
- Ovarian cancer (given with another cancer medicine, carboplatin)
- Bladder cancer (given with another cancer medicine, cisplatin)
- Sometimes biliary tract cancer, according to MedlinePlus
Get medical help straight away if
- Tell your cancer team or hospital straight away about signs of infection, such as a fever or feeling very unwell. Low white blood cells can make infections serious.
- Get emergency help for a severe allergic reaction: rash, hives, swelling of the face, lips, tongue or throat, or trouble breathing.
- Get urgent help for new or worse breathing problems, wheezing, or swelling all over the body with breathlessness.
- Get urgent help for severe chest pain or a fast, uneven or pounding heartbeat.
Side effects, warnings and interactions for Gemcitabine
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Celzar 1000 1000 G injection
Celzar 1000 1000 G injection contains Gemcitabine 1000 G. It is registered with DRAP by Hakimsons (Impex) (Pvt.) Ltd (registration no. 072562). Its official price is PKR 16,961.77 for a pack of Per vial. This price has applied since 23 July 2026. No other brand of Gemcitabine 1000 G in this form is listed in Pakistan.
Other brands of Gemcitabine 1000 G injection in Pakistan
No other brand of Gemcitabine 1000 G injection is listed in Pakistan. See all strengths and forms of Gemcitabine →
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Celzar 1000, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Hakimsons (Impex) (Pvt.) Ltd., Karachi
- DRAP registration
- 072562
- Phone
- +92 21 32314765; +92 21 32314766; +92 21 32312631; +92 21 32315365
- info@hakimsons.com.pk
- Website
- https://hakimsons.com.pk/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 26 October 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (Per vial). Current price PKR 16,961.77, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Celzar 1000 1000 G, Per vial: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/celzar-1000-1000-g-072562-per-vial-hakimsons-impex-pvt-ltd/ (accessed 12 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 16,961.77 | 2026-07-23 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Cite this record
Medicine record · DRAP registration 072562Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.